CMPX

NASDAQStock

Compass Therapeutics, Inc.

$5.14-0.05 (-0.96%)

52-Week Range

$1.46
$6.69

Key Stats

Market Cap

710.8M

P/E Ratio

Dividend Yield

Beta

1.29

Volume

674.4K

Avg Volume

2.2M

Performance

1M

-17.36%

3M

+2.17%

6M

+43.77%

YTD

+0.39%

1Y

+120.85%

3Y

+51.75%

5Y

+46.20%

Price Chart

ETF Exposure

CMPX is held by 66 ETFs

ETFFund NameWeight
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
PreviousPage 2 of 2

About CMPX ETF Exposure

Compass Therapeutics, Inc. (CMPX) is held by 66 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 710.8M, CMPX is a widely held institutional stock. The stock currently trades at $5.14. Investors can gain exposure to CMPX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CMPX, sorted by portfolio weight.